Skip to main content
. 2020 Jul 9;20:214. doi: 10.1186/s12876-020-01361-5

Table 4.

The influence of the use of scopolamine on the AV visualization rate during the FVE and CAE

Use of scopolamine FVE CAE
AV visualization (%). P value AV visualization (%). P value
Completely visualized Partially/not visualized Completely Visualized Partially/not visualized
Yes 20 (38.5) 14 (28.0) 0.30 22 (22.2) 2 (66.7) 0.14
No 32 (61.5) 36 (72.0) 77 (77.8) 1 (33.3)

FVE forward-viewing endoscopy, CAE cap-assisted endoscopy

Values given as no